Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Royalty Pharma plc Class A Ordinary Shares (RPRX) has a market cap of $19.51B with year-over-year revenue growth of +0.0%. Net margin stands at 32.4%. The stock trades at a P/E ratio of 25.3.
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, RPRX posted revenue growth of +0.0% and trades at a P/E of 25.3.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.